Por: Forbes Tech December 05, 2022
Cigna’s pharmacy benefit manager Express Scripts will put “multiple biosimilar versions of Abbvie’s ... [+] expensive rheumatoid arthritis drug Humira in the “same position as the brand” on the PBM’s as a formulary in 2023. AbbVie's signature drug Humira is shown in this illustration Friday, July 18, 2014, in Houston. (AP Photo/David J. Phillip)Copyright 2014 AP. All rights reserved. This material may not be published,... + full article
Forbes USA Business November 13, 2022
This two-part article was researched and written in partnership with , President of Rumbly Health. delved into what a PBM is, why they are under scrutiny, and their eroding position in the market. Amazon, already one of the most highly-valued companies in the world, has been... + más
How To Get Away With Corporate Murder: Unbundling And Disrupting Pharmacy Benefit Managers (Part 1) | Forbes
Louisiana set to expand medical marijuana business, allow for new pharmacies | The Advocate
Forbes USA Tech November 13, 2022
This article was researched and written in partnership with , President of Rumbly Health. If, as Mitt Romney said, a corporation , then is it akin to murder if an idea takes down a company? What about if it takes down an industry? Sam Bender is a centenarian who invests in... + más
How To Get Away With Corporate Murder: Unbundling And Disrupting Pharmacy Benefit Managers (Part 2) | Forbes
Forbes USA Business November 12, 2022
As I suspect that many have limited exposure to small- and mid-cap stocks, we’ve updated our special report, Small Companies, Big Potential. Mid-Cap Value Stocks are AttractiveKovitz We also offer a reminder of the methodology we utilize for all our value-based equity... + más
As The 2022-23 NHL Season Opens, Teams Set New Standards For Salary-Cap Precision | Forbes
Europe's gas price cap leaves some nations dismayed, saying it's far too high | CNBC
RTTNews USA Health October 28, 2022
AbbVie () announced Friday that the European Medicines Agency (EMA) has validated a Marketing Authorization Application (MAA) for epcoritamab (DuoBody-CD3xCD20), an investigational subcutaneous bispecific antibody, for the treatment of adult patients with relapsed/refractory... + más
Don’t Pay for Cord-Blood Banking | The Atlantic
Prime Video’s Aparna Purohit Reveals How Madhuri Dixit Got Onboard For ‘Maja Ma’ | Forbes
WPLG Local 10 USA Health October 22, 2022
WASHINGTON – The Biden Administration and Health & Human Services (HHS) have extended the through January 11, 2023. U.S. Department of Health and Human Services Secretary Xavier Becerra declared the continuation for the 11th time on Friday. According to a news release, “In... + más
Mötley Crüe, Def Leppard Announce 'The World Tour' 2023 | RTTNews
Millions at risk of losing health insurance if U.S. ends Covid public health emergency in January | CNBC
ABC News USA Health October 17, 2022
Health care giant Cigna improperly obtained tens of millions of dollars in Medicare funding by making certain Medicare Part C recipients seem sicker than they actually were, the federal government alleged in a civil lawsuit filed Monday.Cigna submitted false and invalid... + más
How to switch Medicare plans — and why you might want to | CBS News
Medicare annual enrollment -- what you need to know | MarketWatch
RTTNews USA Health October 03, 2022
Shares of Prometheus Biosciences Inc. () closed at an all-time high of $59.01 on Friday (Sep.30, 2022), reflecting a gain of over 100% in 3 months.Prometheus is a biotechnology company pioneering a precision medicine approach in developing novel therapeutic and companion... + más
Dodgers Dugout: Will the next Dodgers closer please stand up? | Los Angeles Times
Brayan Bello stumbles to cap promising rookie campaign and Red Sox again steamrolled by Blue Jays | The Boston Globe
About iurex | Privacy Policy | Disclaimer |